ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 770

Involvement of Iliofemoral and Axillary Arteries in PET-CT May Be Associated with Atherosclerotic Risk Factors in Takayasu’s Arteritis

Sema Kaymaz-Tahra1, Salih Ozguven 2, Ali Ugur Unal 3, Fatma Alibaz-Oner 4, Tunc Ones 2, Tanju Yusuf Erdil 2 and Haner Direskeneli 5, 1Marmara University School of Medicine, Division of Rheumatology, Istanbul, Istanbul, Turkey, 2Marmara University Faculty of Medicine, Nuclear Medicine, Istanbul, Turkey, 3Marmara University Faculty of Medicine, Rheumatology, Istanbul, Turkey, 4Marmara University Faculty of Medicine,Department of Rheumatology,Istanbul,Turkey, Istanbul, Turkey, 5Marmara University, School of Medicine, Division of Rheumatology, Istanbul, Turkey

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: 18FDG PET/CT scan, petvas and atherosclerosis, Takayasu arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster I: Takayasu's Arteritis & Polymyalgia Rheumatica

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: FDG-PET-CT is recommended as one of the imaging modalities for the diagnosis and monitoring of primary large-vessel vasculitis (LVV), such as Takayasu’s arteritis (TAK). Interpretation of FDG uptake is based on the principle of determining the inflammatory metabolic activity in the vessel wall in LVV. However, vascular uptake due to atherosclerosis may be a contributing factor in PET-CT assessment. In this study we aimed to evaluate the characteristics of patients with and without involvement of arteries other than the 9 arteries used for assessing PET Vascular Activity Score (PETVAS), which is developed to determine LVV activity in most-commonly involved arterial areas.

Methods: Patients fulfilling ACR1990 classification criteria for TAK and underwent PET-CT imaging were evaluated retrospectively. Demographic and clinical data were collected from patients’ charts. Traditional cardiovascular risk factors: diabetes, hypertension, hyperlipidemia, smoking history and body mass index (BMI) were evaluated. Nine arterial areas used for assessing PETVAS were ascending aorta, aortic arch, descending aorta, abdominal aorta, right and left carotid arteries, innominate artery, right and left subclavian arteries, as originally suggested. Bilateral axillary arteries and iliofemoral arteries were evaluated as atypical (extra-PETVAS) involvement.

Results: 46 imagings of 34 patients (F/M:28/6) were evaluated. Mean disease duration was 9.3 ±6.5 years and mean age was 40.5± 15.1 years. In the majority of patients aortic arch (87%) was involved followed by ascending aorta (78%) and brachiocephalic artery (50%)(Figure 1). At least one arterial area was involved in 43 images. In 28% of these imagings (12/43), a PET involvement of an artery other than the arteries used for assessing PETVAS, were observed. The mean age of this group was higher than the rest of the group (51.0±16.6 vs 35.8±11.9 years, p=0.01). The number of involved arterial areas (8.5±4.0 vs 3.2±1.5, p=0.000) and total PETVAS scores (10 (2-27) vs 4 (1-17), p=0.013) were higher in atypical arterial involvement group. These patients were also more likely to have the cardiovascular risk factors (Table 1). Patients who had at least 2 cardiovascular risk factors had atypical arterial involvement more frequently (60% (6/10) vs 19% (4/21), p=0.03).

Conclusion: Patients with atypical arterial involvements in PET-CT may have increased atherosclerotic risk factors. These patients had more extended arterial involvement, implying that chronic vascular inflammation may be enhanced by atherosclerosis. Our results suggest that anti-atherosclerotic approaches should be implemented more vigourously in TAK patients.


Disclosure: S. Kaymaz-Tahra, None; S. Ozguven, None; A. Unal, None; F. Alibaz-Oner, None; T. Ones, None; T. Erdil, None; H. Direskeneli, None.

To cite this abstract in AMA style:

Kaymaz-Tahra S, Ozguven S, Unal A, Alibaz-Oner F, Ones T, Erdil T, Direskeneli H. Involvement of Iliofemoral and Axillary Arteries in PET-CT May Be Associated with Atherosclerotic Risk Factors in Takayasu’s Arteritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/involvement-of-iliofemoral-and-axillary-arteries-in-pet-ct-may-be-associated-with-atherosclerotic-risk-factors-in-takayasus-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/involvement-of-iliofemoral-and-axillary-arteries-in-pet-ct-may-be-associated-with-atherosclerotic-risk-factors-in-takayasus-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology